Improving access to HbA1c measurement in sub Saharan Africa
Glycated haemoglobin (HbA1c) is the best surrogate of average blood glucose control in people with diabetes. Large-scale studies in the USA and UK have demonstrated that lowering HbA1c significantly reduces diabetes complications. Moreover, immediate feedback of HbA1c measurement to patients improves control. However, HbA1c measurement is unavailable in most parts of Africa, a continent with one of the highest burden of diabetes. To translate these evidences, we will provide affordable access to HbA1c measurement and relevant education in 2 African countries, aiming at a significant improvement in diabetes control. We will develop a training and cost-recovery scheme with local health authorities for long-term sustainability.
